An overview of the potential of immunotherapy in treating lymphoma
T-cell lymphoma: autologous or allogeneic transplant?
A novel WINDOW of opportunity for young mantle cell lymphoma patients
Allogeneic transplant is not the quintessential treatment for ALL anymore!
Enhancing immunotherapy for CLL patients with ibrutinib